Cargando…
Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy
SIMPLE SUMMARY: Physicians face therapeutic choices in an increasing number of IBD patients with current or past malignancy. Even if uncontrolled IBD may lead to severe complications, promoting cancer relapse through the use of immunomodulators is a concern. There is a lack of scientific evidence su...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954488/ https://www.ncbi.nlm.nih.gov/pubmed/36831424 http://dx.doi.org/10.3390/cancers15041083 |